Cell Penetrating Peptide Market By Type (Protein-derived CPPs, Synthetic CPPs, Chimeric CPPs) Application (Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging, Others) By End-User (Pharmaceutical Companies, Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations (CROs), Diagnostic Laboratories), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1653 | 220 Pages


Report Coverage:

By Type

  • Protein-derived CPPs
  • Synthetic CPPs
  • Chimeric CPPs

By Application

  • Drug Delivery
  • Gene Delivery
  • Diagnostics
  • Molecular Imaging
  • Others

By End-User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic & Research Institutions
  • Contract Research Organizations (CROs)
  • Diagnostic Laboratories

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Bachem Holding AG
  • Bio-Synthesis Inc.
  • PolyPeptide Laboratories AB
  • Tocris Bioscience
  • Avidity Biosciences
  • CordenPharma
  • Creative Peptides
  • PEPperPRINT GmbH
  • CPC Scientific Inc.
  • Chemos GmbH & Co. KG
  • PeptiDream Inc.
  • Bio-Techne Corporation
  • SynPeptide Co., Ltd.
  • Merck KGaA
  • GL Biochem Ltd.
  • Evonik Industries AG

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.